VAERS Reports UJ594AAA

VAERS 2581179

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ594AAA

gering

Staat: CA
Alter: 1,3
Geschlecht: M
Eingang: 14.02.2023
Impfdatum: 31.01.2023
Beginn: 31.01.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Medication error No adverse event

Symptomtext

expired acthib administered with no reported adverse event; Initial information received on 07-Feb-2023 regarding an unsolicited valid non-serious case received via health professional and physician. GMI number: 01481511. This case involves 16 months old male patient to whom expired vaccine HIB (PRP/T) VACCINE [ACT-HIB] administered with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. This case is linked to seven patient cases 2023SA046745, 2023SA045123, 2023SA045388, 2023SA046763, 2023SA046771 and 2023SA046834. On 31-Jan-2023, the patient received expired fourth dose of suspect HIB (PRP/T) VACCINE at dose 0.5 ml once (lot: UJ594AAA, expiry date: 26-Oct-2022) via intramuscular route in the right deltoid for Immunization with no reported adverse event (expired product administered) at same day latency. This situation is reported as a medication error due to seven patients being administered expired ACTHIB. Action taken: Not applicable. It was not reported if the patient received a corrective treatment for the event. At time of reporting, the outcome was Unknown for the event expired product administered. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2580102

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ594AAA

gering

Staat: CA
Alter: 1,4
Geschlecht: M
Eingang: 13.02.2023
Impfdatum: 20.12.2022
Beginn: 20.12.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Medication error No adverse event

Symptomtext

administered ACT-HIB that expired on 26-OCT-2022 with no reported adverse event; Initial information received on 07-Feb-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 17 months old male patient who was administered HIB (PRP/T) vaccine [ACT-HIB] that expired on 26-oct-2022 with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included influenza vaccine for prophylactic vaccination; and pneumococcal vaccine CONJ 7V (CRM197) (Prevnar) for prophylactic vaccination. On 20-Dec-2022, the patient was administered 0.5 mL of suspect HIB (PRP/T) vaccine powder and solvent for solution for injection (1X; batch/lot number: UJ594AAA; strength, dose: unknown) via intramuscular route in the left deltoid for immunization that expired on 26-oct-2022 (expired product administered) (latency: same day). Action taken: Not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: 01481406: 01481498: 01481505: 01481508:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2580042

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ594AAA

gering

Staat: CA
Alter: 1,3
Geschlecht: F
Eingang: 13.02.2023
Impfdatum: 10.01.2023
Beginn: 10.01.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Medication error No adverse event

Symptomtext

administered ACTHIB that expired with no reported adverse event; Initial information received on 07-Feb-2023 regarding an unsolicited valid non-serious case received from health professional and Physician. GMI number: 01481508. This case involves 16 months old female patient to whom expired HIB (PRP/T) VACCINE [ACT-HIB] was administered with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. This case is linked to seven patient cases 2023SA046771, 2023SA046778, 2023SA046763, 2023SA046745, 2023SA045388 and 2023SA045123. Concomitant medications included Pneumococcal Vaccine CONJ 7V (CRM197) (Prevnar) for Immunization. On 10-Jan-2023, the patient received expired vaccine fourth dose of suspect HIB (PRP/T) vaccine Powder and solvent for solution for injection at dose 0.5 ml once (lot: UJ594AAA, expiry date: 10-Oct-2022) via intramuscular route in the right deltoid for Immunization with no reported adverse event (expired product administered) at same day latency. It was reported that they inquired about next steps to take and what information to tell the parents. This situation is reported as a medication error due to seven patients being administered expired ACTHIB. Action taken: Not applicable. It was not reported if the patient received a corrective treatment for the event. At time of reporting, the outcome was Unknown for the event expired product administered. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2580041

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ594AAA

gering

Staat: CA
Alter: 1,3
Geschlecht: M
Eingang: 13.02.2023
Impfdatum: 10.01.2023
Beginn: 10.01.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Medication error No adverse event

Symptomtext

administered ACTHIB that expired on 26OCT2022 (with no reported adverse event); Initial information received on 07-Feb-2023 regarding an unsolicited valid non-serious case received from other health professional. This case is linked to cases 2023SA046834, 2023SA046778, 2023SA046763, 2023SA046745, 2023SA045388 and 2023SA045123. This case involves a 16 month old male patient who was administered HIB (PRP/T) vaccine [ACT-HIB] that expired on 26oct2022 with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included pneumococcal vaccine CONJ 7V (CRM197) (Prevnar) for Immunisation. On 10-Jan-2023, the patient received an expired 0.5 mL dose 4 of suspect HIB (PRP/T) vaccine, powder and solvent for solution for injection (lot: UJ594AAA; expiry date: 26-Oct-2022) via intramuscular route in the left deltoid for immunization with no reported adverse event (expired product administered) (same day latency). Action taken: not applicable. At time of reporting, the outcome was Unknown for the event administered acthib that expired on 26oct2022 (with no reported adverse event). This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2580040

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ594AAA

gering

Staat: CA
Alter: 1,3
Geschlecht: M
Eingang: 13.02.2023
Impfdatum: 01.11.2022
Beginn: 01.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Medication error No adverse event

Symptomtext

patients being administered expired ACTHIB with no reported adverse event; Initial information received on 07-Feb-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to case 2023SA046771. This case involves a 15 months old male patient who being administered expired haemophilus type B (HIB) vaccine (ACT-HIB) HIB (PRP/T) vaccine [ACT-HIB] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. At the time of the event, the patient had ongoing Influenza Concomitant medications included pneumococcal vaccine CONJ 7V (CRM197) (Prevnar) for Immunisation. On 01-Nov-2022, the patient received a dose 4 at dosage 0.5 mL of suspect HIB (PRP/T) vaccine, Powder and solvent for solution for injection, (lot number: UJ594AAA and expiry date: 26-Oct-2022 via intramuscular route in the left vastus lateralis for immunization with no reported adverse event (expired product administered) (latency: same day). No lab data was reporte. Action taken was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Flu
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2579409

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ594AAA

gering

Staat: CA
Alter: -
Geschlecht: M
Eingang: 10.02.2023
Impfdatum: 22.11.2022
Beginn: 22.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Medication error

Symptomtext

administered expired ACTHIB with no reported AE; Initial information received on 07-Feb-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 19 months old male patient who got administration of expired HIB (PRP/T) vaccine [ACT-HIB] with no reported ae. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Pneumococcal vaccine CONJ 7V (CRM197) (Prevnar) for Prophylactic vaccination. On 22-Nov-2022, the patient who got administration of expired HIB (PRP/T) vaccine [ACT-HIB] with no reported ae (expired product administered) and received a dose 4 of 0.5 ml once Powder and solvent for solution for injection of standard strength (lot: UJ594AAA, expiry date: 26-Oct-2022) via intramuscular route in the right deltoid. Action taken: not applicable. Outcome: Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2579408

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ594AAA

gering

Staat: CA
Alter: 1,5
Geschlecht: M
Eingang: 10.02.2023
Impfdatum: 15.11.2022
Beginn: 15.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Medication error

Symptomtext

administered expired ACTHIB with no adverse event; Initial information was received on 07-Feb-2023 regarding an unsolicited valid non-serious case received from an other health professional. This case involves a 18 months old male patient who received administered expired HIB (PRP/T) vaccine [ACT-HIB] with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included pneumococcal vaccine CONJ 7v (CRM197) (Prevnar) and Influenza vaccine for Immunisation. On 15-Nov-2022, the patient received expired 0.5 ml dose 4 of suspect HIB (PRP/T) vaccine [ACT-HIB] (strength: standard) (lot number: UJ594AAA, expiry date: 26-Oct-2022, formulation: Unknown) via intramuscular route in the right deltoid for Immunization (Immunisation) with no adverse event (expired product administered) (latency: same day) It was reported that "seven patients were administered ACTHIB that expired on 26-OCT-2022. Wanting to know next steps to take and what information to tell the parents. See related cases and AE reports: Patient 1: 01481406 Patient 3: 01481502 Patient 4: 01481503 Patient 5: 01481505 Patient 6: 01481508 Patient 7: 01481511" No lab data reported. Action taken: not applicable. Outcome: Unknown for the event administered expired acthib with no adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: 01481406: 01481502: 01481503: 01481505: 01481508: 01481511:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2513683

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ594AAA

gering

Staat: TX
Alter: 1,3
Geschlecht: F
Eingang: 22.11.2022
Impfdatum: 04.11.2022
Beginn: 04.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / RL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Medication error No adverse event

Symptomtext

an expired dose of ACTHIB was administered to a patient, with no reported adverse event; Initial information received on 14-Nov-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 15 months old female patient who experienced an expired dose of acthib was administered to a patient, with no reported adverse event while receiving vaccine hib (prp/t) vaccine (Act-Hib). The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Pneumococcal Vaccine Conj 13V (CRM197). On 04-Nov-2022, the patient received a dose 4 of suspect hib (prp/t) vaccine Powder and solvent for solution for injection at a dose of 0.5 ml with lot UJ594AAA and expiry date 26-Oct-2022 via intramuscular route in the right thigh for Immunization. On 04-Nov-2022 (latency: same day) the patient developed a non-serious an expired dose of acthib was administered to a patient, with no reported adverse event (expired product administered) following the administration of hib (prp/t) vaccine. Action taken: not applicable. Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: PNEUMOCOCCAL VACCINE CONJ 13V (CRM197)
Allergien: -
Vorherige Impfungen: -

VAERS 2509274

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ594AAA

gering

Staat: UT
Alter: 1,0
Geschlecht: M
Eingang: 16.11.2022
Impfdatum: 07.11.2022
Beginn: 07.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / RL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Medication error No adverse event

Symptomtext

administered expired acthib to a patient, with no reported adverse event; Initial information was received on 09-Nov-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves 12 months old male patient who experienced administered expired acthib to a patient, with no reported adverse event while receiving vaccine hib (prp/t) vaccine [ACT-HIB]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included pneumococcal vaccine CONJ 13V (CRM197) (Prevnar 13) for Prophylactic vaccination. On 07-Nov-2022, the patient received a DOSE 4 of suspect hib (prp/t) vaccine Powder and solvent for solution for injection at a dosage of 0.5 ml (lot UJ594AAA, expiry date - 26-Oct-2022) via intramuscular route in the right thigh for immunization. On 07-Nov-2022 the patient developed a non-serious event of administered expired acthib to a patient, with no reported adverse event (expired product administered) (latency: same day) following the administration of hib (prp/t) vaccine. Action taken with haemophilus type b (hib) vaccine (ACT-HIB) was not applicable. It was not reported if the patient received a corrective treatment for the event (administered expired acthib to a patient, with no reported adverse event). At time of reporting, the outcome was Unknown for the event administered expired acthib to a patient, with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: PREVNAR 13
Allergien: -
Vorherige Impfungen: -

VAERS 2505319

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ594AAA

gering

Staat: NJ
Alter: 1,3
Geschlecht: M
Eingang: 11.11.2022
Impfdatum: 01.11.2022
Beginn: 01.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Medication error No adverse event

Symptomtext

an expired dose of ACTHIB was administered with no reported adverse event; Initial information received on 02-Nov-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 15 months old male patient who was administered an expired dose of HIB (PRP/T) VACCINE [ACT-HIB] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (DAPTACEL) and INFLUENZA VACCINE INACT SPLIT 3V (FLULAVAL), both for Immunization. On 01-Nov-2022, the patient received 0.5 mL of Booster (dose 4) of suspect HIB (PRP/T) VACCINE (lot UJ594AAA and expiry date: 26-Oct-2022) via intramuscular route in the left thigh for prophylactic immunization. On 01-Nov-2022, (latency: same day) an expired dose of acthib was administered with no reported adverse event (expired product administered) following the administration of HIB (PRP/T) VACCINE. Action taken with HAEMOPHILUS TYPE B (HIB) VACCINE (ACT-HIB) was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: DAPTACEL; FLULAVAL
Allergien: -
Vorherige Impfungen: -

VAERS 2501372

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ594AAA

gering

Staat: CA
Alter: 1,2
Geschlecht: F
Eingang: 08.11.2022
Impfdatum: 28.10.2022
Beginn: 28.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Medication error No adverse event

Symptomtext

of ACTHIB that was expired by two days with no reported adverse event; Initial information received on 28-Oct-2022 regarding an unsolicited valid non-serious case received from a physician. This case involves a 14 months old female patient who was given act-hib that was expired by two days with no reported adverse event , after receiving vaccine HIB (PRP/T) VACCINE [ACT-HIB]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 28-Oct-2022, the patient received a once dose of suspect HIB (PRP/T) VACCINE( lot UJ594AAA and expiration date: 28-Oct-2022) at a dose of 0.5ml at an unknown route in the left thigh. as prophylactic vaccination. On 28-Oct-2022 (latency: same day) ,the patient was administered acthib that was expired by two days with no reported adverse event (expired product administered). Action taken :not applicable. It was not reported if the patient received a corrective treatment for the event. Outcome: unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2396508

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ594AAA

gering

Staat: CA
Alter: 1,3
Geschlecht: F
Eingang: 29.07.2022
Impfdatum: 29.07.2022
Beginn: 29.07.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Product administration error

Symptomtext

Only diluent was injected (vaccine was not mixed). No symptoms reported. Reporting vaccine administration error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product administration error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -